- Home
- ACIU vs CFFI Comparison
ACIU vs CFFI Comparison
Compare ACIU & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- CFFI
- Stock Information
- Founded
- ACIU 2003
- CFFI 1927
- Country
- ACIU Switzerland
- CFFI United States
- Employees
- ACIU N/A
- CFFI N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- CFFI Major Banks
- Sector
- ACIU Health Care
- CFFI Finance
- Exchange
- ACIU Nasdaq
- CFFI Nasdaq
- Market Cap
- ACIU 189.1M
- CFFI 211.9M
- IPO Year
- ACIU 2016
- CFFI 1998
- Fundamental
- Price
- ACIU $2.07
- CFFI $67.27
- Analyst Decision
- ACIU Strong Buy
- CFFI
- Analyst Count
- ACIU 1
- CFFI 0
- Target Price
- ACIU $12.00
- CFFI N/A
- AVG Volume (30 Days)
- ACIU 139.5K
- CFFI 38.4K
- Earning Date
- ACIU 08-05-2025
- CFFI 07-23-2025
- Dividend Yield
- ACIU N/A
- CFFI 2.74%
- EPS Growth
- ACIU N/A
- CFFI 10.01
- EPS
- ACIU N/A
- CFFI 6.68
- Revenue
- ACIU $32,014,254.00
- CFFI $116,421,000.00
- Revenue This Year
- ACIU N/A
- CFFI N/A
- Revenue Next Year
- ACIU $533.21
- CFFI N/A
- P/E Ratio
- ACIU N/A
- CFFI $10.08
- Revenue Growth
- ACIU 91.20
- CFFI 0.67
- 52 Week Low
- ACIU $1.43
- CFFI $41.48
- 52 Week High
- ACIU $4.26
- CFFI $89.90
- Technical
- Relative Strength Index (RSI)
- ACIU 56.20
- CFFI 63.27
- Support Level
- ACIU $1.65
- CFFI $60.76
- Resistance Level
- ACIU $2.17
- CFFI $60.10
- Average True Range (ATR)
- ACIU 0.17
- CFFI 2.12
- MACD
- ACIU -0.01
- CFFI 0.73
- Stochastic Oscillator
- ACIU 70.37
- CFFI 97.42
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.